• Site Search
  • News
  • Product
  • Zhejiang Medical Technology Development Co., Ltd.

    2020 year
    25 day
    "Xenical" activates the life Launch meeting of Xenical® back to Chinese mainland ended successfully

    The heady fragrance of laurel blossoms wafts through the fresh air in the golden autumn. The launch meeting of Xenical® back to Chinese mainland was successfully held by Hong Kong Winhealth Pharma Group on Sept. 25. It means imported original Orlistat Capsules (brand name: Xenical®) return to the market of Chinese mainland officially.

    Several honored guests, including Mr. Wang Wei, president, founder and CEO of Hong Kong Winhealth Pharma Group, Prof. Zou Dajin, chief physician of Endocrinology Department of Shanghai Tenth People’s Hospital, Prof. Zhao Xiaolong, chief physician of Endocrinology Department of Shanghai Huashan Hospital and Prof. Xie Ming, chief physician of Department of Gastrointestinal Surgery of Affiliated Hospital of Zunyi Medical University, attended the meeting and witnessed the important moment of Xenical® back to Chinese mainland.


    Mr. Wang Wei, president, founder and CEO of Hong Kong Winhealth Pharma Group gave an opening speech, and a warm welcome and sincere thanks to experts taking time out to attend the launch meeting of Xenical®, and wished a complete success of the meeting on behalf of the staff of Winhealth Pharma Group. Mr. Wang Wei said, Winhealth Pharma was engaged in bringing the high-quality healthcare products and medical technologies worldwide into China all the time, and the return of Xenical® to Chinese mainland permitted high-quality imported Orlistat to provide more solutions for clinical first-line healthcare professionals and benefit the vast patients.


    Return!  Return!

    Then, Professors Zou Dajin, Zhao Xiaolong and Xie Ming combined the theories and practice, explained how to manage obese patients with diabetes mellitus (DM), introduced how to take in nutrition reasonably for DM patients from the point of medical nutrition and presented which obese patients needed weight loss treatment from the point of surgery in simple terms.

    At last, the launch meeting of Xenical® held by Hong Kong Winhealth Pharma Group ended successfully in a warm interaction atmosphere.

    About Winhealth Pharma

    Hong Kong Winhealth Pharma Group is an innovative Hong Kong-headquartered and China-focused pharmaceutical company, is committed to filling the huge medical demand gap of Greater China market by introducing and commercializing the patents and owns Established Pharmaceutical Division (EPD) and rare diseases-orientated Innovative Therapeutics Division (ITD). The former covers brand-name drugs in five fields: respiratory diseases and anti-infection, cardiovascular diseases, digestion and liver diseases, dermatology and cosmetic medicine, and urinary system diseases. Winhealth Pharma provides integrated service of local research and development, registration and commercialization for the internationally renowned pharmaceutical enterprises, and has become one of well-known CDCOs (contract development and commercialization organizations) in China, and the clients include several transnational pharmaceutical enterprises listed in the world’s top 500 enterprises. Headquartered in Hong Kong, Winhealth Pharma also establishes the operating centers and offices in Hangzhou, Shanghai, Beijing, Guangzhou, Hainan, Tokyo and Munich. Visit for more information.

    3rd Floor, Winhealth Industrial Park, No. 272 Huancheng East Road, Xiacheng District, Hangzhou, Zhejiang, China
    BD@winhealth.Hk (overseas)
    0571-8718 6358    4008393773 ( Product Hotline )
    Copyright ©2019 - 2024 Zhejiang Medical Technology Development Co., Ltd.